Navigation Links
Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements
Date:2/4/2011

OSLO, Norway, Feb. 4, 2011 /PRNewswire/ -- Photocure (OSE: PHO), a Norwegian specialty pharmaceutical company focused in dermatology and cancer, today announced positive results from its consumer trial with Allumera™, a breakthrough cosmetic treatment formulated to improve the skin's appearance.

The RevitAll study was performed with a standard cosmetic protocol and designed to confirm if treatment with Allumera™ improves skin appearance, when compared to exposure by light alone.  The study also looked into longevity of results.

This controlled, prospective study enrolled 120 women to receive three treatments, four weeks apart.  The total duration of the study was five months.  Half the study participants received Allumera™ plus light, while the remaining received light alone (control group).  Participants were monitored for three months following the last treatment to evaluate which effects were long-lasting.  The study evaluations included both objective and subjective assessments.  The objective assessments included measurement of pores, skin firmness/elasticity, skin tone (radiance/luminosity), skin surface topography and tolerability.  

At the five month evaluation, participants who received Allumera™ for one hour followed by exposure to light, showed a significant 44% reduction in the appearance of pores (p<0.001), when compared to baseline, and the difference between the two groups was statistically significant (p=0.002).  A statistically significant improvement (p<0.0001) in skin firmness and suppleness was also observed for the Allumera group when compared to the control group.  A 35% improvement in the appearance of skin tone (p<0.05) was also found, but this, however, was not statistically significant when compared to the control group.

"The results from our RevitAll study provide a solid foundation for our efforts to commer
'/>"/>

SOURCE Photocure
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Holdings, Inc. (NYSE: HRC ) invites you ... Stanley Global Healthcare Conference on September 8, 2014, at ... listen to the live discussion via the internet link ... http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP .  A recorded replay of the discussion ... live event and accessible at the links above until ...
(Date:8/27/2014)... Reportlinker.com announces that a new market ... Global Animal Health Market 2014-2018 ... Health Animal health refers to veterinary services intended ... enhance their quality of life, increase their lifetime, ... Global Animal Health market covers the following segments: ...
(Date:8/27/2014)... 2014 Sihuan Pharmaceutical Holdings Group Ltd. ... leading pharmaceutical company with the largest cardio-cerebral vascular ... prescription drug market, today announced the unaudited ... (collectively the "Group") for the six months ended ... HighlightsFor the Six months ended 30 JuneKey Income ...
Breaking Medicine Technology:Global Animal Health Market 2014-2018 2Global Animal Health Market 2014-2018 3Global Animal Health Market 2014-2018 4Global Animal Health Market 2014-2018 5Global Animal Health Market 2014-2018 6Global Animal Health Market 2014-2018 7Sihuan Pharmaceutical Announces 2014 Interim Results 2Sihuan Pharmaceutical Announces 2014 Interim Results 3Sihuan Pharmaceutical Announces 2014 Interim Results 4Sihuan Pharmaceutical Announces 2014 Interim Results 5Sihuan Pharmaceutical Announces 2014 Interim Results 6Sihuan Pharmaceutical Announces 2014 Interim Results 7
... Ga., Nov. 16 Brookstone Pharmaceuticals, an emerging specialty pharmaceutical ... the company to Acella Pharmaceuticals, LLC. This decision has ... more accurately mirrors our commitment to "Accelerating the Health Care ... Mark Pugh, CEO states, "As we have grown over the ...
... Methodist Dallas Medical Center recently made history when it became ... kidney transplant on an HIV positive patient. The patient, a ... a life free from dialysis for the first time in ... with transplant surgeons Dr. Jose Castillo-Lugo, Dr. David Nessar, and ...
Cached Medicine Technology:Methodist Dallas Medical Center First in Metroplex to Perform Kidney Transplant on HIV Positive Patient 2Methodist Dallas Medical Center First in Metroplex to Perform Kidney Transplant on HIV Positive Patient 3
(Date:8/27/2014)... New York (PRWEB) August 27, 2014 ... filed in U.S. courts on behalf of women who ... uterine morcellation, Bernstein Liebhard LLP reports. According to court ... on August 18th in the U.S. District Court, Northern ... patient who claims the use of a power morcellator ...
(Date:8/27/2014)... Austin, TX (PRWEB) August 27, 2014 Picture, ... no, not Holmes and Watson but more of a Mr. ... Glenn Davis, in terms of personalities and world view. This ... The University of Texas at Austin, and Mr. Outside was ... professor’s family physician, his new girlfriend, and a gaggle of ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 When Jagger was ... call from his mother; one that he credits as one ... His mom had news that she could set him up ... people with disabilities. Jagger took that job, and he has ... Throughout these past two decades, he also worked in school ...
(Date:8/27/2014)... 2014 The newest Abington Health ... September 8, 2014. This new 15,000 square foot, $5 ... primary care practices and walk-in laboratory services. ... exciting endeavor for Abington Health as the healthcare landscape ... Health. “Establishing a location in Lower Gwynedd allows us ...
(Date:8/27/2014)... By Amy Norton ... -- People who take part in clinical trials of new ... typical heart patient, a new study confirms. Experts said ... of the American Medical Association , aren,t surprising -- but ... trials are enrolling a more select patient population that is ...
Breaking Medicine News(10 mins):Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 4Health News:UW Rankin Self-Publishes Debut Novel, Sublimity: Perchance to Dream, A Speculative Science Mystery 2Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 2Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 3Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 4Health News:Abington Health Opens New Health Center in Lower Gwynedd 2Health News:Heart Studies Don't Reflect Real-World Patients, Study Finds 2Health News:Heart Studies Don't Reflect Real-World Patients, Study Finds 3
... , , , ... 22, 2010 , Forterus, Inc. (Pink Sheets: FTER) announced its results ... CEO, stated, "This has been a transformational year for Forterus and ... believe we have a strong foundation from which to grow our ...
... , Jan. 23 Following the announced end of search ... international aid agency Oxfam said: , "The end of search and rescue ... the survivors is the priority now. , "Hundreds of thousands who lost ... latrines to contain the spread of disease. They need shelter and simple ...
... less, MRI scans show , SATURDAY, Jan. 23 (HealthDay News) ... have less activity in the frontal lobes of their brain, ... activate a portion of your frontal lobes, the more accurate ... yourself as desirable or better than your peers, the less ...
... (PHILADELPHIA) People who are in car crashes ... other injuries at nights or on weekends do not ... disparities as patients who suffer heart attacks, strokes, cardiac ... according to new research from the University of Pennsylvania ...
... 2010 A new American Cancer Society report outlines 21 challenges ... of issues to be addressed and expertise needed to reduce ... low- and middle-income nations that are the target of the ... will appear in the January/February issue of CA: A ...
... is one of the ten most disabling diseases in the ... financial burden on health services as average life expectancy increases. ... nearly 27 million Americans or 12.1% of the adult population ... 2001 study showed that the disease costs US health services ...
Cached Medicine News:Health News:Forterus Announces Fiscal Year 2009 Financial Results 2Health News:Forterus Announces Fiscal Year 2009 Financial Results 3Health News:Forterus Announces Fiscal Year 2009 Financial Results 4Health News:Oxfam Relief Efforts Continue In Haiti 2Health News:Self-Image Linked to Activity in Frontal Lobe of Brain 2Health News:Trauma patients safe from mortality risks associated with so-called 'weekend effect' 2Health News:Trauma patients safe from mortality risks associated with so-called 'weekend effect' 3Health News:Global tobacco report outlines 21 challenges for 21st century 2Health News:Global tobacco report outlines 21 challenges for 21st century 3Health News:Cartilage repair can improve life, ease burden on health services 2
This double-up gel dryer system, 200-240 V, includes 2 Model 583 gel dryers, HydroTech™ vacuum pump, and double-up rack....
The GelAir™ dryer is a component of the GelAir drying system. Supplied as a 230 V, 50 Hz gel drying oven....
... is an electrophoresis gel vacuum dryer that removes ... these gels onto cellophane or filter paper for ... which heat gels from above. The drying surface ... unit includes power cord, porous gel support, transparent ...
Capable of producing up to 500 volts and 500 milliamps, this power supply is ideal for PAGE, SDS-PAGE, DNA or RNA submarine gels as well as all types of small format transfer apparatus....
Medicine Products: